Cytokines in neuropathic pain;Zytokine bei neuropathischen schmerzen

Anaesthesist

Volumn 50, Issue 6, 2001, Pages 416-426

  Sommer, C ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cytokines; Neuropathy; Pathophysiology; Wallerian degeneration

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; CYTOKINE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; PROSTAGLANDIN; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; HUMAN; HYPERALGESIA; KNOCKOUT MOUSE; NERVE DEGENERATION; NEUROPATHY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; REVIEW; SENSORY NERVE;

ANIMALS; CYTOKINES; HUMANS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0034957520     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010100135     Document Type: Review

References (140)

1. Tumor necrosis factors: Developments during the last decade
2. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice
3. Role of TNF-alpha but not NGF in murine hyperalgesia induced by parasitic infection
4. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: Potential role of IL-6 in neuropathic pain
5. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: Possible immune modulation in neuropathic pain(1)
6. Administration of intravenous immunoglobulin (IVIG)in vivo - down-regulatory effects on the IL-1 system
7. Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation
8. Tumor necrosis factor production in patients with leprosy
9. A neuroimmune interaction in painful peripheral neuropathy
10. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
11. Rat Schwann cells produce interleukin-1
12. Interleukin-1 and nociception in the rat
13. Central effects of tumor necrosis factor and interleukin-1alpha on nociceptive thresholds and spontaneous locomotor activity
14. Presence of a reduced opioid response in interleukin-6 knock out mice
15. Expression des ARNm de l'interleukine 1 beta, de l'interleukine 6 et du tumor necrosis factor alpha au cours de la regeneration du nerf sciatique de rat apres perte de substance
16. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury
17. Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction
18. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin
19. Brain-derived TNF alpha: Involvement in neuroplastic changes implicated in the conscious perception of persistent pain
20. The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia
21. Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines
22. Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: A feasibility study
23. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model
24. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy
25. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model
26. Local effects of recombinant rat interleukin-6 on the peripheral nervous system
27. Interleukin-1 and interleukin-1 antagonism
28. Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor
29. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation
30. Randomised double-blind comparison of chimeric monoklonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
31. TNF-alpha expression in schmerzhaften und nicht-schmerzhaften neuropathien
32. Defective inflammatory response in interleukin 6-deficient mice
33. Interleukin-1 β as a potent hyperalgesic agent antagonized by a tripeptide analogue
34. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia
35. Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain
36. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia
37. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat
38. Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy
39. Upregulation of the tumor necrosis factor receptor 1 and 2 in mouse sciatic nerve after chronic constrictive injury
40. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury
41. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn metenkephalin
42. Thalidomide in painful AIDS-associated proctitis
43. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: Comparison between immune-mediated demyelination and Wallerian degeneration
44. Wirkung von gepoolten humanen immunglobulinen auf das schmerzniveau bei fibromyalgiepatienten
45. Interleukin-1beta in immune cells of the abdominal vagus nerve: A link between the immune and nervous systems?
46. Macrophage systems in peripheral nerves. A review
47. Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor
48. Pain modulatory actions of cytokines and prostaglandin E2 in the brain
49. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: Studies with Interleukin-1β and tumor necrosis factor-α
50. Brain-derived TNF alpha mediates neuropathic pain
51. Interleukin-1 beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system
52. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
53. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system
54. Nociceptive and inflammatory effects of subcutaneous TNF alpha
55. Formation of ion-permeable channels by tumor necrosis factor-alpha
56. Cytokines of the lung
57. A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma
58. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation
59. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1
60. Cytokine involvement in dynorphin-induced allodynia
61. Cytokines in sural nerve biopsies
62. Partial sciatic nerve transection as a model of neuropathic pain: A qualitative and quantitative neuropathological study
63. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury
64. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve
65. Mapping the lectin-like activity of tumor necrosis factor
66. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin
67. Tumor necrosis factor locus: Genetic organisation and biological implications
68. Proinflammatory pathways in cervicogenic headache
69. Serum interleukin-1 beta is increased in cluster headache
70. The interleukin-receptor complex and interleukin-1 signal transduction
71. Upregulation of cyclooxygenase 2 is dependent on tumor necrosis factor receptor 1 and 2 after chronic constriction injury
72. TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies
73. Axotomized and intact muscle afferents but no skin afferents develop ongoing discharges of dorsal root ganglion origin after peripheral nerve lesion
74. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
75. Induction of interleukin-6 in axotomized sensory neurons
76. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice
77. Peripheral nerve fibroblasts as a source of IL-6, TNF alpha and IL-1 and their modulation by IFN gamma
78. Interleukin-1 induces analgesia in mice by a central action
79. Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons
80. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain
81. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats
82. The opposing effects of interleukin-1 beta microinjected into the preoptic hypothalamus and the ventromedial hypothalamus on nociceptive behavior in rats
83. Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats
84. Tumor necrosis factor-alpha in peripheral nerve lesions
85. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: Effects on heat-evoked calcitonin gene-related peptide release from rat skin
86. 9 bradykinin-mediated thermal hyperalgesia in the rat
87. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10
88. TNF and related molecules: Trends in neuroscience and clinical applications
89. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome
90. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice
91. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor
92. Interleukin-1 activity in lesioned peripheral nerve
93. Signals for proinflammatory cytokine secretion by human Schwann cells
94. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia
95. Involvement of interleukin-1 beta, nerve growth factor, and prostaglandin-E2 in the hyperalgesia induced by intraplantar injections of low doses of thymulin
96. Nerve lesions induced by macrophage activation
97. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states
98. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue
99. ICAM and TNF: ICAM regulation in mice with painful mononeuropathy
100. Retrograde transport of tumor necrosis factor-alpha is unlikely to cause neuropathic pain
101. Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels
102. Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements
103. Upregulation and interaction of TNF alpha and gelatinases A and B in painful peripheral nerve injury
104. Axonal transport of TNF-alpha in painful neuropathy: Altered distribution of ligand and receptors
105. IL-10 as a mediator in the HPA axis and brain
106. The cytokine theory of headache
107. Thalidomide as a blocker of TNF production
108. Tierexperimentelle untersuchungen bei neuropathischem schmerz: Die pathogene und therapeutische bedeutung von zytokinen und zytokinrezeptoren
109. Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: Differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity
110. Pathology of experimental compression neuropathy producing hyperesthesia
111. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy
112. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1
113. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve
114. Anti-TNF neutralizing antibodies reduce pain-related behavior in two models of painful mononeuropathy
115. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy
116. Etanercept reduces hyperalgesia in experimental painful neuropathy
117. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat
118. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres
119. Nerve injury, axonal degeneration and neural regeneration: Basic insights
120. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system
121. Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA
122. Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion
123. gp130 cytokines, leukemia inhibitory factor and interleukin-6, induce neuropeptide expression in intact adult rat sensory neurons in vivo: Time-course, specificity and comparison with sciatic nerve axotomy
124. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons
125. "Inflammatory" cytokines: Neuromodulators in normal brain?
126. Pain related behavior in TNF-receptor deficient mice
127. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors
128. Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves
129. Antiinflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression
130. Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection
131. Neurocircuitry of illness-induced hyperalgesia
132. Characterization of cytokine-induced hyperalgesia
133. Mechanisms of tumor necrosis factor-a (TNF-a) hyperalgesia
134. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states
135. Changes in plasma cytokines associated with peripheral nerve injury
136. Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor alpha
137. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section
138. Biphasic effects of intracerebroventricular interleukin-1 beta on mechanical nociception in the rat
139. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice
140. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin